We are live on ! Find out more
OSIR

Osiris Therapeutics, Inc. Common Stock
OSIR

Delisted

OSIR was delisted on the 16th of April, 2019.

Back to rankings

Fund managers haven’t disclosed any holdings of OSIR yet.

OSIR Hedge Fund Activity: Q3 2019 in Review

0 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q3 2019, worth a combined $0 — down 100% from $1K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of OSIR and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Financial Gravity Asset Management, exiting entirely with an estimated $1K sold.

  • 0 institutional investors held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q3 2019, down from 1 in Q2 2019.
  • Funds reported $0 of Osiris Therapeutics, Inc. Common Stock stock for Q3 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q3 2019 and 1 closed out, a net change of -1 holder.
  • The largest Osiris Therapeutics, Inc. Common Stock seller in Q3 2019 was Financial Gravity Asset Management, an estimated $1K sold.

Based on aggregated 13F filings for Q3 2019.